Filing Details
- Accession Number:
- 0001127602-20-031027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-09 17:25:04
- Reporting Period:
- 2020-12-07
- Accepted Time:
- 2020-12-09 17:25:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-07 | 1,467 | $12.21 | 1,467 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 5,000 | $14.22 | 6,467 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 3,533 | $12.21 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 10,000 | $19.15 | 20,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 1,696 | $153.86 | 18,304 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 2,459 | $154.73 | 15,845 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 789 | $155.50 | 15,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 1,597 | $156.95 | 13,459 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 4,863 | $158.07 | 8,596 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 2,344 | $159.14 | 6,252 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 528 | $159.75 | 5,724 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 2,619 | $161.65 | 3,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 2,962 | $162.64 | 143 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-07 | 143 | $163.49 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-07 | 1,467 | $0.00 | 1,467 | $12.21 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-07 | 5,000 | $0.00 | 5,000 | $14.22 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-07 | 3,533 | $0.00 | 3,533 | $12.21 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-07 | 10,000 | $0.00 | 10,000 | $19.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,478 | 2027-02-23 | No | 4 | M | Direct | |
| 50,209 | 2028-02-28 | No | 4 | M | Direct | |
| 202,291 | 2027-10-03 | No | 4 | M | Direct | |
| 14,790 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.24 to $154.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.25 to $155.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.26 to $156.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.51 to $157.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.60 to $158.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.65 to $159.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.66 to $160.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.05 to $162.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.17 to $163.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.37 to $163.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.
- 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.
- 229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years).
- This option is fully vested and exercisable.
Billionaire Hedge Funds
